Arthritis is a highly prevalent and heterogeneous disease with multifactorial pathogenesis that remains incompletely understood, creating substantial challenges for mechanistic investigation and therapeutic development. Conventional cell-based assays and animal models exhibit inherent limitations in preclinical drug screening, largely due to insufficient tissue-level complexity and interspecies differences, respectively, which contribute to the high attrition rate in clinical translation. Recent advances in bioengineering and microphysiological technologies have enabled the development of in vitro models that more faithfully recapitulate joint architecture and function, providing improved platforms for mechanistic investigation and therapeutic evaluation. This review outlines the core components of in vitro arthritic model construction, including cell sources, matrix materials, and disease-inducing factors, and systematically categorizes existing platforms into planar systems and three-dimensional culture approaches. Representative studies are analyzed to highlight model design strategies, characterization methodologies, and scalability considerations. Current challenges and future perspectives are also discussed, with an emphasis on the promise of these emerging systems to deepen mechanistic understanding and accelerate the translation of clinically effective therapies.